A Phase I Study to Evaluate the Safety and Immunogenicity of Heterologous Boost Immunizations With MVA-CMDR
NCT01889719
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
HIV
Interventions
BIOLOGICAL:
MVA-CMDR
Sponsor
Rockefeller University